Institutional Research Archive

Hedge Fund Letters Archive

Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.

Quarter	Letter Date	Fund Name	QTD	YTD	Tickers	Themes	Quick Take

Home Letters Funds Account

Meridian Growth Fund 2024 Q3 Investor Letter | Buyside Digest

Back to Fund Profile (Meridian Growth Fund)

Primary Source Intelligence • Q3 2024 Letter Analysis

Meridian Growth Fund Quarterly Analysis

Buyside Digest is not affiliated with, and does not endorse, Meridian Growth Fund. This analysis is provided for institutional research purposes only and is not investment advice.

Fund Returns

Annualized+11.21%

Digest Analysis

Quick Take

"Emphasizing downside protection through quality businesses with recurring revenues. The fund trimmed appreciated positions including Smartsheet and Doximity while adding to OKTA on weakness."

Executive Summary

The Meridian Growth Fund returned 6.78% net in Q3 2024, slightly underperforming the Russell 2500 Growth Index's 6.99% return. The fund's investment approach centers on high-quality businesses with recurring revenue and sustainable competitive advantages, emphasizing downside protection over return maximization. This defensive strategy proved effective during market volatility, outperforming the index on all six days when it declined 2% or more. Key detractors included OKTA, Ziff Davis, and Global Foundries, while top contributors were Doximity, Smartsheet, and Cooper Companies. The fund trimmed several positions based on valuation discipline as stocks appreciated. Looking forward, management expects continued Fed rate cuts but remains cautious on consumer-facing stocks due to persistent price pressures. Healthcare represents an area of growing confidence, with the fund maintaining an overweight position based on attractive valuations and improving fundamentals. The strategy continues prioritizing risk management while seeking quality businesses with stable revenues at attractive prices.

Unlock Full Institutional Analysis

Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.

Sign In to Unlock (3 Free Credits)View Pricing Tiers

Institutional Meta Strategy

Meta Strategy Gauges

Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.

Signal Matrix

Market Conviction

68%

CautiousHigh

Moderate (68%)

The fund demonstrates moderate-high conviction through concentrated top 10 holdings representing significant portfolio weights (3.35% to 2.33%), clear thesis explanations for individual positions, and decisive trimming/adding actions based on valuation discipline. Named positions with specific rationale and sizing decisions indicate solid conviction, though the diversified approach across multiple sectors prevents a higher score.

Growth Outlook

25%

BearishBullish

Bearish (25%)

The manager expresses cautious optimism with Fed rate cuts providing relief, but acknowledges ongoing consumer pressures and takes 12-18 months for rate cuts to impact the economy. Mixed signals with some positive healthcare outlook but continued caution on consumer sectors.

Risk Appetite

10%

DefensiveAggressive

Defensive (10%)

The fund maintains a defensive posture, emphasizing downside protection over return opportunity. Portfolio is underweight consumer-facing stocks due to ongoing concerns, though overweight healthcare based on improving fundamentals. Overall positioning reflects cautious risk appetite.

Capital Deployment

43%

De-riskingDeploying

Net Neutral (43%)

The fund engaged in net trimming activity during the quarter, reducing positions in Doximity, Smartsheet, Cooper Companies, Ziff Davis, and Global Foundries while only adding to OKTA. This represents modest capital harvesting rather than deployment, though the activity appears driven by valuation discipline rather than broad risk reduction.

Forward Guidance

0%

CautiousExpansionary

Cautious (0%)

The manager takes a balanced approach with selective positioning - remaining cautious on consumer stocks while gradually gaining confidence in healthcare. No clear directional bias toward aggressive deployment or defensive positioning, maintaining current selective approach.

Language Signal

15%

BearishBullish

Bearish (15%)

Language is predominantly cautious with terms like 'remain cautious,' 'ongoing price pressures,' and 'until we see clearer signs of stabilization.' Some positive language around healthcare opportunities and Fed rate cuts, but overall tone leans slightly toward risk awareness.

Perceived Risk

45%

Low RiskElevated

Moderate Risk (45%)

The manager acknowledges moderate risks including ongoing consumer price pressures, 12-18 month lag time for rate cut impacts, and sector-specific challenges in semiconductors and consumer-facing businesses. Risk discussion is present but not alarmist, focusing on specific identifiable concerns rather than systemic threats.

Opportunity Density

55%

ScarceAbundant

Selective (55%)

The manager sees selective opportunities, particularly in healthcare where they are gaining confidence and maintaining overweight positioning. However, they remain cautious on consumer-facing stocks and note challenges in semiconductors, suggesting a mixed opportunity environment requiring selectivity rather than broad-based opportunity.

Time Horizon

70%

Short-TermLong-Term

Decade+ (70%)

The fund emphasizes long-term growth of capital as its investment objective and focuses on businesses with sustainable competitive advantages. The approach of trimming positions based on valuation discipline rather than short-term catalysts, combined with emphasis on quality businesses and resilient portfolio construction, indicates a multi-year investment horizon.